Clinical Trial Update: Herombopag for Chemotherapy-induced Thrombocytopenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is recruiting in China to evaluate Herombopag for chemotherapy-induced thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Herombopag (herombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Chemotherapy-induced Thrombocytopenia, Herombopag | Phase 2 | Status: RECRUITING